Axsome Therapeutics, Inc. (AXSM) Files An 8-K Results of Operations and Financial Condition
Item2.02.Results of Operations and Financial
Condition.
On November14, 2016, Axsome Therapeutics,Inc. (the Company)
issued a press release announcing its financial results for the
three months ended September30, 2016 and an update on the
Companys operations. The Company is furnishing a copy of the
press release, which is attached hereto as Exhibit99.1.
In accordance with General Instruction B.2 of Form8-K, the
information included in this Current Report on Form8-K (including
Exhibit99.1 hereto), shall not be deemed filed for the purposes
of Section18 of the Securities Exchange Act of 1934, as amended
(the Exchange Act), or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference
into any filing made by the Company under the Exchange Act or
Securities Act of 1933, as amended, except as shall be expressly
set forth by specific reference in such a filing.
Item 9.01.Financial Statements and
Exhibits.
(d) Exhibits.
|
Exhibit Number |
|
Description |
|
99.1 |
Press release dated November14, 2016. |
About Axsome Therapeutics, Inc. (AXSM)
